M Sverdlov

Plain English
This study looked at how a protein called ABCA1, found in certain immune cells called myeloid cells, impacts the ability of these cells to fight cancer. Researchers discovered that when ABCA1 is active, it helps immune cells better infiltrate tumors and support other immune cells, which can improve the overall response to cancer treatments. Specifically, mice without ABCA1 in their immune cells had larger tumors and were more resistant to immune therapies, indicating that ABCA1 plays a critical role in cancer resistance. Who this helps: This benefits cancer patients by potentially improving immune therapies.

Plain English
Researchers studied certain proteins related to selenium in breast cancer tissues from African American and Caucasian women to understand why outcomes differ based on race. They found that levels of two proteins, SELENOF and eIF4a3, were higher in the breast cancer tissues of African American women, along with specific genetic variations in the selenium transporter protein SELENOP. This matters because it sheds light on biological factors that may contribute to the worse breast cancer outcomes often seen in African American women, potentially guiding future treatments and diagnostic methods. Who this helps: This information benefits patients, particularly African American women facing breast cancer and healthcare providers looking for targeted treatment options.

Plain English
This study looked at two proteins, SELENOF and EIF4A3, in colon cancer to understand how they interact and affect patient outcomes. Researchers found that when EIF4A3 levels are high, low levels of SELENOF are linked to worse survival rates in patients. Specifically, patients with high EIF4A3 and low SELENOF had a poor prognosis, emphasizing the importance of studying these protein interactions for better cancer treatment strategies. Who this helps: This helps doctors and researchers working on treatments for colon cancer patients.

Plain English
Researchers studied a specific protein called ABCA1 in immune cells related to cancer, focusing on how it affects the way these cells support or fight tumors. They found that when ABCA1 is active in myeloid immune cells (like macrophages), it boosts their ability to attack tumors and helps other immune cells function better. In tests on mice, removing ABCA1 led to more tumor growth and spread, suggesting that adjusting this protein's activity could improve cancer treatment outcomes. Who this helps: This benefits cancer patients by potentially enhancing the effectiveness of immune therapies.

Plain English
This study looked at two proteins, MRTFA and MRTFB, that are involved in breast cancer growth and spread, specifically focusing on how these proteins act in human tumors and their surrounding environment. Researchers found that both proteins are active in cancer cells, but MRTFA levels were higher in metastatic tumors from African American patients, a group facing significant breast cancer mortality. The findings highlight how these proteins could be linked to immune system suppression within the tumor, potentially guiding new treatments for breast cancer. Who this helps: Patients, particularly African American women with breast cancer.

Plain English
This study looked at how autoantibodies in bullous pemphigoid (BP), a skin condition that causes blisters, affect skin cells called keratinocytes. Researchers found that these autoantibodies trigger a specific immune response in keratinocytes, leading to the release of inflammatory substances that could worsen the disease. In experiments with mice, blocking a key part of this response reduced disease severity and inflammation. Who this helps: This helps patients with bullous pemphigoid and their doctors by providing insights into potential treatments.

Plain English
This research studied how blocking the mTOR protein affects fat and cholesterol levels in cancer cells. The scientists found that when mTOR is inhibited, it leads to increased cholesterol being taken up and moved to where it's needed in the cell, which helps cancer cells survive under stress. In tests with mice, combining mTOR blockage with other treatments reduced tumor growth significantly. Who this helps: Patients with cancer may benefit from new treatments targeting mTOR.

Plain English
This study looked at how a specific protein called PRMT6 is expressed in lung tumors among different races and sexes, particularly in relation to the level of violence in their neighborhoods. Researchers found that Black men were 7.8 times more likely, and Black women were 1.8 times more likely, to have high levels of PRMT6 compared to White men and women when living in low-violence areas. As neighborhood violence increased, these odds became even higher, suggesting that social stress could play a role in lung cancer disparities. Who this helps: This information benefits patients, particularly Black men with lung cancer, by highlighting the need for tailored treatment and support based on social factors.

Plain English
This study looked at how two factors—race and living in a violent neighborhood—affect levels of a protein (PRMT6) related to lung cancer in patients. It found that Black men were 7.8 times more likely to have high PRMT6 levels compared to White men, and those living in high-violence areas had lower levels of this protein. This matters because understanding these differences can help address the higher lung cancer risks in Black men and potentially improve prevention efforts. Who this helps: Patients, particularly Black men at risk for lung cancer.

Plain English
Researchers studied the role of specific proteins, GATA-3 and XPO1, in T-cell lymphomas, a type of cancer that often resists standard treatments. They found that blocking XPO1 made these cancers more sensitive to treatments, particularly in cases where key tumor suppressor genes like TP53 and PTEN were lost. This approach could be effective for altering cancer growth and altering the supportive environment around tumors, which is important for improving treatment options for difficult-to-treat lymphomas. Who this helps: This benefits patients with T-cell lymphomas, especially those who haven't responded to traditional therapies.

Plain English
This study looked at how two proteins, MRTFA and MRTFB, behave in invasive breast cancer and its surrounding environment. Researchers found that both proteins are activated in cancer cells, but their levels vary for different types of breast cancer and are notably higher in metastatic tumors from African American patients. Understanding these patterns is important because it highlights potential new treatment strategies that could address racial disparities in breast cancer outcomes. Who this helps: This information helps patients by providing insights for targeted breast cancer therapies, particularly for African American women.

Plain English
This study looked at a protein called ERBB3 in patients with castration-sensitive prostate cancer (CSPC) to see how it affects treatment outcomes. Researchers found that high levels of ERBB3 were linked to more advanced disease at diagnosis and that it could signal which patients might not respond well to standard therapies like enzalutamide. Specifically, they noted a positive correlation between ERBB3 levels and androgen receptor activity, even in patients with low levels of male hormones, indicating that targeting ERBB3 might help those who don’t respond well to traditional treatments. Who this helps: This research benefits patients with prostate cancer by identifying a potential biomarker for better treatment strategies.

Plain English
This study looked at how a protein called NR0B2 affects immune cells in the body, specifically those that can suppress the immune response in tumors. Researchers found that NR0B2 helps limit the growth of regulatory T cells, which are known to dampen the immune system's ability to fight tumors. Mice that did not have NR0B2 showed faster tumor growth, highlighting NR0B2's potential as a new target for cancer treatments. Who this helps: This research benefits cancer patients, particularly those with breast and solid tumors.

Plain English
This study looked at a protein called NR0B2 that helps the immune system fight cancer, particularly in breast tumors. Researchers found that when NR0B2 is present, patients tend to have better survival rates and a higher chance of benefiting from immune therapies. They developed a better treatment, DSHN-OMe, that is more effective at fighting tumors and regulating immune cells compared to earlier versions. Who this helps: This helps cancer patients, especially those with breast cancer, by improving treatment options.

Plain English
This study focused on creating a computer program using artificial intelligence to detect and classify specific types of fractures in the upper arm bone from standard X-ray images. The researchers tested the program on thousands of X-rays and found that it correctly identified fractures 94% of the time, but it struggled with identifying important fracture details, such as significant bone displacement, with only 35% accuracy. This is important because while the AI can help rule out some fractures, it is not reliable enough for doctors to fully depend on it for making treatment decisions. Who this helps: This benefits doctors and radiologists working with patients who have shoulder injuries.

Plain English
This study examined how antibodies from patients with bullous pemphigoid (BP) affect skin cells called keratinocytes. The researchers found that these antibodies significantly increased inflammation in the keratinocytes, leading to the release of several inflammatory substances. For instance, they discovered elevated levels of cytokines like IL-6 and IL-24, and had a specific focus on a protein called MyD88, which plays a key role in this response. Who this helps: This research benefits patients with bullous pemphigoid by clarifying how their immune response contributes to skin inflammation and blistering.

Plain English
This study focused on a rare type of lymphoma called nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL), examining the role of a protein called polo-like kinase 1 (PLK1) in its growth. Researchers found that PLK1 was present in all 76 NLPHL samples studied, while less than 5% of classic Hodgkin lymphoma cases showed it. The presence of PLK1 was linked to more advanced disease, suggesting that targeting PLK1 could be a new treatment approach and that a strong immune response may help control tumor growth in NLPHL. Who this helps: This helps patients with nodular lymphocyte-predominant Hodgkin lymphoma and their doctors.

Plain English
This study focused on a compound called α-mangostin and its ability to break down androgen receptors, which are important for the growth of prostate cancer cells. The researchers found that cells treated with α-mangostin had reduced levels of both normal and mutated androgen receptors, indicating that this compound can effectively target these proteins. This is significant because many current prostate cancer treatments fail to work against mutated receptors, leading to drug resistance; thus, α-mangostin may offer a new way to treat or manage prostate cancer. Who this helps: This helps patients with prostate cancer and their doctors by providing a potential new treatment option.

Plain English
The study looked into how a protein called eIF4a3 affects the levels of another protein, SELENOF, in prostate cancer. Researchers found that eIF4a3 is present in higher amounts in prostate cancer tissue and reduces SELENOF levels, which are lower in cancer compared to healthy tissue. Specifically, higher levels of eIF4a3 were linked to lower SELENOF levels, and when eIF4a3 was blocked, SELENOF levels increased. This matters because understanding this relationship can help identify potential targets for prostate cancer treatment. Who this helps: This information benefits patients with prostate cancer and their doctors by providing insights into potential new therapies.

Plain English
This study looked at how a specific protein called NR0B2 in immune cells can affect breast cancer progression. Researchers found that when NR0B2 was removed, breast tumors grew faster and spread more, but by using certain small molecules to stimulate NR0B2, they were able to reduce the growth of tumor-suppressing immune cells, slow down tumor growth, and improve cancer treatment effectiveness by reducing metastatic growth. This is important because it shows that targeting NR0B2 could help boost cancer therapies for breast cancer. Who this helps: This benefits breast cancer patients seeking more effective treatments.

Plain English
This study focused on improving how doctors measure PRMT6, a protein linked to how serious lung cancer can be, by using machine learning technology. The researchers developed an automated system that analyzes lung cancer tissue samples and found that it closely matched the accuracy of human pathologists, with a correlation score of 0.88 and a very high reliability rating of 0.96. This matters because it streamlines the process of evaluating a key cancer marker, making it faster and easier to identify patients at risk and tailor treatments. Who this helps: Patients with lung cancer and their doctors.

Plain English
This study looked at a skin condition called epidermolysis bullosa acquisita (EBA), which causes inflammation and blistering due to a response to certain antibodies. Researchers found that specific markers on neutrophils, a type of immune cell, were significantly altered in the skin of patients with EBA compared to those in the bloodstream. However, even though these markers were upregulated, they did not affect the severity of the disease in experimental models. Who this helps: This research benefits patients with EBA and their doctors by providing insights into the disease's immune response.

Plain English
This study looked at two different methods of delivering a cancer drug, doxorubicin, directly into liver tumors in rabbits: a conventional method and a newer drug-eluting method. It found that while both methods effectively delivered the drug and caused similar levels of tumor damage (about 39% for conventional and 37% for drug-eluting), the conventional method achieved much better drug coverage of the tumor (10.8% versus 2.3%). This matters because better drug delivery could lead to more effective cancer treatments. Who this helps: This helps patients with liver tumors by potentially improving the effectiveness of their treatment.

Plain English
Researchers examined levels of a compound called CML, which builds up in tissues and may relate to the biology of prostate cancer, in tissue samples from 118 patients with benign and cancerous prostate tissue. They found that CML levels were lower in cancerous areas compared to benign ones, and these lower levels were linked to a higher percentage of African ancestry in the patients. This is important because it could provide insight into differences in prostate cancer biology based on ancestry, potentially guiding future research and treatment strategies. Who this helps: This helps patients and doctors by informing approaches to prostate cancer based on ancestry-related biological differences.

Plain English
This study looked at how women and men work in the gig economy, focusing on teachers at an online school in Eastern Europe. It found that women taught fewer classes than men overall and particularly worked less in the evenings, which led to fewer paid hours and contributed to a gender pay gap. This matter because it highlights existing inequalities in flexible work settings that should be addressed to ensure fair pay for women. Who this helps: Women in the gig economy.

Plain English
This study looked at how a specific protein and its receptor affect the healing of skin wounds in obese mice with type 2 diabetes. Researchers found that high levels of this protein, CCL28, and its receptor, CCR10, reduced the availability of a key enzyme (eNOS) that helps wounds heal. By using a special peptide to block the interaction between CCR10 and eNOS, they saw improved wound healing in mice, reducing the healing time significantly. Who this helps: This benefits patients with type 2 diabetes, particularly those suffering from chronic wounds like diabetic foot ulcers.

Plain English
This study looks at two different methods for weight loss and reducing the risk of colorectal cancer: daily calorie restriction and time-restricted eating. Researchers found that time-restricted eating led to a weight loss of about 3% to 5% among adults with obesity, while also improving factors like insulin sensitivity. Understanding the most effective ways to manage obesity is important because it can lower the chances of developing colorectal cancer. Who this helps: This research benefits patients with obesity at risk for colorectal cancer.

Plain English
This study looked at how a signaling pathway called Notch affects the development of aggressive lymphomas from mature T cells, specifically a type called peripheral T-cell lymphoma (PTCL). The researchers found that Notch signaling is active in many PTCL cases and that higher Notch1 activation is linked to increased cancer cell growth. Blocking Notch signaling in laboratory models slowed the progression of these lymphomas, suggesting that new treatments that target this pathway could be effective. Who this helps: Patients with aggressive T-cell lymphomas could benefit from new treatment strategies targeting Notch signaling.

Plain English
This study looked at a protein called GATA-3 and its role in a type of blood cancer known as T-cell neoplasms, which include some aggressive lymphomas that often lead to poor patient outcomes. The researchers found that GATA-3 acts like a cancer-causing gene in these conditions, and they also discovered specific processes that can potentially be targeted for new treatments. Since most patients with GATA-3 driven T-cell neoplasms face a high risk of dying within a few years, improving our understanding of GATA-3 could lead to better therapies and outcomes for these patients. Who this helps: Patients with T-cell lymphomas linked to GATA-3.

Plain English
Researchers discovered that certain immune cells called macrophages play a critical role in helping a deadly blood cancer called peripheral T-cell lymphoma grow, and that cancer cells actively recruit and sustain these macrophages. They found that a drug called pacritinib, which blocks two specific proteins (CSF1R and JAK), can effectively eliminate these protective macrophages and slow cancer progression in laboratory models. This discovery opens a new treatment pathway for patients with this aggressive cancer by targeting not just the cancer cells themselves, but the immune system's support network that keeps them alive.

Plain English
This study looked at a protein called SELENOF and how its loss affects prostate cancer cells. Researchers found that when the levels of SELENOF were decreased in lab-grown prostate cells, those cells began to grow and move more aggressively, similar to cancer cells. This is important because lower SELENOF levels are linked to worse outcomes in prostate cancer, especially in African American men, who have a higher risk of dying from this disease. Who this helps: This information helps doctors and researchers working with prostate cancer patients, particularly in understanding risks for African American men.

Plain English
This study looked at how certain genes respond to high glucose levels in people with type 1 diabetes, comparing those with and without diabetic retinopathy (a complication that can lead to vision loss). The researchers identified a gene called folliculin that showed a strong link to the risk of developing diabetic retinopathy; specifically, the gene was more active in individuals who had this eye condition. Understanding these genetic factors is important because it can help in predicting who might be at higher risk for eye problems due to diabetes. Who this helps: This helps doctors and researchers in identifying at-risk patients to provide earlier interventions.

Plain English
The study looked at a protein called caveolin-1 (Cav1) and how its modification affects the formation and release of small pockets called caveolae in cells. Researchers found that when Cav1 is modified at a specific site (Tyr-14), it causes these pockets to swell and become more numerous—specifically, cells with this modification made 50% more vesicles compared to cells without it. This is important because understanding how Cav1 works can help scientists figure out how cells take in materials from their environment, which could lead to advancements in treating certain diseases. Who this helps: This benefits researchers and medical professionals working on drug delivery and cellular uptake mechanisms.

Plain English
This study examined how certain proteins help cells absorb and transport important substances like insulin. Researchers found that when albumin (a type of protein) was added to lung cells, it activated RalA, which led to increased uptake of a fluorescently labeled protein called BSA. They discovered that RalA works together with other proteins and activates an enzyme called PLD2, which produces a molecule called phosphatidic acid that is crucial for this absorption process. Who this helps: This research benefits doctors and scientists studying drug delivery and treatments for diseases related to blood vessel function.

Plain English
This study examined a case of a 39-year-old woman who developed severe esophageal dilation after undergoing abdominoplasty, a surgery often performed on patients who have lost a lot of weight. The dilation caused her to experience respiratory distress, with her esophagus expanding to 47 mm and pressing against her trachea. The symptoms improved quickly after treating the problem and releasing fluid from her gastric band, highlighting the need to adjust gastric bands before such surgeries to prevent complications. Who this helps: This information benefits patients who have had bariatric surgery and are considering abdominoplasty.

Plain English
This study explored how a protein called N-cadherin influences brain development by affecting the activity of beta-catenin, a key player in neuron formation. Researchers found that when N-cadherin was reduced, there was decreased activation of another protein, AKT, leading to problems with neuron formation and survival; specifically, they observed more neurons dying and an earlier shift to becoming neurons instead of remaining in a precursor state. These findings are important because they reveal how N-cadherin and AKT work together to ensure healthy brain development. Who this helps: This helps patients with neurodevelopmental disorders and their doctors, by providing insights into brain development processes.

Plain English
This study focused on understanding how cells take in substances and recycle their membranes through a process called endocytosis, specifically looking at two main pathways: caveolae and clathrin-mediated endocytosis. Researchers found that different proteins work together to form vesicles, which are small bubbles that help transport nutrients, hormones, and drugs into cells, while also playing a role in how some pathogens invade. This research is important because it sheds light on how disruptions in these processes can lead to diseases and can help improve drug delivery methods. Who this helps: This benefits patients needing better drug treatments and doctors looking to improve therapeutic strategies.

Plain English
This study looked at a protein called filamin A and its role in how cells called endothelial cells, which line blood vessels, manage important substances like proteins and hormones. The researchers found that when filamin A was reduced, the uptake of albumin (a protein in the blood) dropped by about 35% and its transport dropped by 60%. This is significant because it shows how filamin A helps regulate the movement of essential molecules in the body, which can affect vascular health. Who this helps: This research benefits doctors and patients by improving our understanding of vascular health and potential treatments for related diseases.

Plain English
This research studied how a specific process in our cells, called caveolae-mediated endocytosis, works, especially focusing on how a protein called Src tyrosine kinase is involved. The authors found that Src activation is crucial for caveolae to detach from the cell membrane and transport important substances like drugs and nutrients. This understanding is significant as it can lead to better ways to deliver treatments within the body and improve overall health. Who this helps: This benefits patients needing targeted drug delivery and doctors looking for effective treatment methods.

Plain English
This study looked at how certain metal compounds interact with alcohols at low temperatures. Researchers tested three metals—iron, ruthenium, and osmium—and found that osmium had the strongest interactions, with an increase in strength measured from iron to osmium. Specifically, they discovered that the ability of the metal to form bonds with alcohol depends on how acidic the alcohol is and the type of solvent used. Who this helps: This research benefits chemists and scientists working on developing new materials and processes in chemistry.

Plain English
This study looked at the impact of a medication called tranexamic acid (TA) on bleeding and blood transfusion needs after heart surgery known as coronary artery bypass grafting. Researchers found that patients who received TA had significantly less bleeding (about 194 mL compared to 488 mL) and needed fewer blood transfusions (0.52 units versus 1.68 units) than those who received a placebo. This is important because reducing bleeding and the need for blood can lead to safer surgeries and quicker recovery. Who this helps: This benefits heart surgery patients by minimizing complications and promoting faster recovery.

Plain English
This study looked at how blood flows to the brain during a procedure where circulation is stopped, using two different methods: retrograde (backward flow) and antegrade (forward flow). The researchers tested this on 24 rabbits, and they found that the retrograde method led to significantly better blood flow to the brain, with scores of 4.67 out of 5 in some cases, compared to low scores of 0 or 0.17 for the antegrade method. This matters because ensuring better blood flow to the brain during critical surgeries can potentially improve outcomes for patients undergoing heart procedures. Who this helps: Patients undergoing heart surgery.